{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:10:27Z","timestamp":1793999427545,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Open access funding provided by Universit\u00e0 degli Studi di Padova within the CRUI-CARE Agreement."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eat Weight Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Obesity negatively affects physical and psychological health and increases health care costs. Although there is increasing interest in early diagnosis and timely intervention, there are several principles of care included in the current guidelines for clinical management of obesity that can potentially be updated and improved to address the \u201cclinical inertia\u201d and, consequently, to optimize the management of adult obesity. Using an online Delphi-based process, an Italian board of experts involved in the management of obesity discussed the usefulness of a pro-active approach to the care of patients with obesity, providing a consensus document with practical indications to identify risk factors for morbidity and death and raise awareness throughout the treatment continuum, including the early stages of the disease. In clinical practice, it seems inappropriate to delay an intervention that could avoid progression to a more severe level of obesity and\/or prevent the onset of obesity-related comorbidities.<\/jats:p><jats:p><jats:bold>Level of evidence<\/jats:bold> Level V, report of expert committee.<\/jats:p>","DOI":"10.1007\/s40519-022-01402-w","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T09:10:00Z","timestamp":1652778600000},"page":"2653-2663","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Updating obesity management strategies: an audit of Italian specialists"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4883-8980","authenticated-orcid":false,"given":"Luca","family":"Busetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Carbonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Caretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Cricelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giorgino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Gnessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Medea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pappagallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferruccio","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Sbraccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Antonio","family":"Zappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,17]]},"reference":[{"key":"1402_CR1","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","volume":"390","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2017","unstructured":"NCD Risk Factor Collaboration (NCD-RisC) (2017) Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults. Lancet 390:2627\u20132642. https:\/\/doi.org\/10.1016\/S0140-6736(17)32129-3","journal-title":"Lancet"},{"key":"1402_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2458-9-88","volume":"9","author":"DP Guh","year":"2009","unstructured":"Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH (2009) The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 9:88. https:\/\/doi.org\/10.1186\/1471-2458-9-88","journal-title":"BMC Public Health"},{"key":"1402_CR3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/obr.12157","volume":"15","author":"JA Bell","year":"2014","unstructured":"Bell JA, Kivimaki M, Hamer M (2014) Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Rev 15:504\u2013515. https:\/\/doi.org\/10.1111\/obr.12157","journal-title":"Obes Rev"},{"key":"1402_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S2213-8587(15)00086-8","volume":"3","author":"ML Mongraw-Chaffin","year":"2015","unstructured":"Mongraw-Chaffin ML, Peters SAE, Huxley RR, Woodward M (2015) The sex-specific association between BMI and coronary heart disease: a systematic review and meta-analysis of 95 cohorts with 1.2 million participants. Lancet Diabetes Endocrinol 3:437\u2013449. https:\/\/doi.org\/10.1016\/S2213-8587(15)00086-8","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1402_CR5","doi-asserted-by":"publisher","first-page":"i2156","DOI":"10.1136\/bmj.i2156","volume":"353","author":"D Aune","year":"2016","unstructured":"Aune D, Sen A, Prasad M, Norat T, Janszky I, Tonstad S, Romundstad P, Vatten LJ (2016) BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ 353:i2156. https:\/\/doi.org\/10.1136\/bmj.i2156","journal-title":"BMJ"},{"key":"1402_CR6","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S0140-6736(16)30175-1","volume":"388","author":"Global BMI Mortality Collaboration","year":"2016","unstructured":"Global BMI Mortality Collaboration (2016) Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet 388:776\u2013786. https:\/\/doi.org\/10.1016\/S0140-6736(16)30175-1","journal-title":"Lancet"},{"key":"1402_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41591-020-0803-x","volume":"26","author":"F Rubino","year":"2020","unstructured":"Rubino F, Puhl RM, Cummings DE, Eckel RH, Ryan DH, Mechanick JI, Nadglowski J, Ramos Salas X, Schauer PR, Twenefour D, Apovian CM, Aronne LJ, Batterham RL, Berthoud HR, Boza C, Busetto L, Dicker D, De Groot M, Eisenberg D, Flint SW, Huang TT, Kaplan LM, Kirwan JP, Korner J, Kyle TK, Laferr\u00e8re B, le Roux CW, McIver L, Mingrone G, Nece P, Reid TJ, Rogers AM, Rosenbaum M, Seeley RJ, Torres AJ, Dixon JB (2020) Joint international consensus statement for ending stigma of obesity. Nat Med 26:485\u2013497. https:\/\/doi.org\/10.1038\/s41591-020-0803-x. Accessed 25 Oct 2021","journal-title":"Nat Med"},{"key":"1402_CR8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1159\/000442721","volume":"8","author":"V Yumuk","year":"2015","unstructured":"Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, Toplak H, Obesity Management Task Force of the European Association for the Study of Obesity (2015) European guidelines for obesity management in adults. Obes Facts 8:402\u2013424. https:\/\/doi.org\/10.1159\/000442721","journal-title":"Obes Facts"},{"key":"1402_CR9","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, ESC Scientific Document Group (2018) 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J 39:3021\u20133104. https:\/\/doi.org\/10.1093\/eurheartj\/ehy339","journal-title":"Eur Heart J"},{"key":"1402_CR10","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","volume":"32","author":"Z Reiner","year":"2011","unstructured":"Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees (2011) (2011) ESC\/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 32:1769\u20131818. https:\/\/doi.org\/10.1093\/eurheartj\/ehr158","journal-title":"Eur Heart J"},{"key":"1402_CR11","volume-title":"Gazing into the oracle: the Delphi method as its application to social policy and public health","author":"M Adler","year":"1996","unstructured":"Adler M, Ziglio E (1996) Gazing into the oracle: the Delphi method as its application to social policy and public health. Jessica Kingsley Publishers, London"},{"key":"1402_CR12","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1287\/mnsc.9.3.458","volume":"9","author":"N Dalkey","year":"1963","unstructured":"Dalkey N, Helmer O (1963) An experimental application of the DELPHI method to the use of experts. Manag Sci 9:458\u2013467. https:\/\/doi.org\/10.1287\/mnsc.9.3.458","journal-title":"Manag Sci"},{"key":"1402_CR13","volume-title":"Principles of forecasting","author":"G Rowe","year":"2001","unstructured":"Rowe G, Wright G (2001) Expert opinions in forecasting: role of the Delphi technique. In: Armstrong JS (ed) Principles of forecasting. Kluwer Academic Press, Norwell"},{"key":"1402_CR14","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/ijo.2008.11","volume":"32","author":"A Romero-Corral","year":"2008","unstructured":"Romero-Corral A, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo-Clavell ML, Korinek J, Allison TG, Batsis JA, Sert-Kuniyoshi FH, Lopez-Jimenez F (2008) Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes 32:959\u2013966. https:\/\/doi.org\/10.1038\/ijo.2008.11","journal-title":"Int J Obes"},{"key":"1402_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP161365.GL","volume":"3","author":"WT Garvey","year":"2016","unstructured":"Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R, Reviewers of the AACE\/ACE Obesity Clinical Practice Guidelines (2016) American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract Suppl 3:1\u2013203. https:\/\/doi.org\/10.4158\/EP161365.GL","journal-title":"Endocr Pract Suppl"},{"key":"1402_CR16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/ajcn\/76.4.743","volume":"76","author":"S Zhu","year":"2002","unstructured":"Zhu S, Wang Z, Heshka S, Heo M, Faith MS, Heymsfield SB (2002) Waist circumference and obesity associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr 76:743\u2013749. https:\/\/doi.org\/10.1093\/ajcn\/76.4.743","journal-title":"Am J Clin Nutr"},{"key":"1402_CR17","unstructured":"Standard Italiani per la Cura dell\u2019Obesit\u00e0 SIO-ADI 2016\u20132017. Sbraccia P (ed) Vivavoce srl 2017; 279\u2013282. https:\/\/www.sio-obesita.org\/wp-content\/uploads\/2017\/09\/STANDARD-OBESITA-SIO-ADI.pdf. Accessed 25 Oct 2021"},{"key":"1402_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ypmed.2004.05.025","volume":"40","author":"SD Hsieh","year":"2005","unstructured":"Hsieh SD, Muto T (2005) The superiority of waist-to-height ratio as an anthropometric index to evaluate clustering of coronary risk factors among non-obese men and women. Prev Med 40:216\u2013220. https:\/\/doi.org\/10.1016\/j.ypmed.2004.05.025","journal-title":"Prev Med"},{"key":"1402_CR19","doi-asserted-by":"publisher","first-page":"E875","DOI":"10.1503\/cmaj.191707","volume":"192","author":"S Wharton","year":"2020","unstructured":"Wharton S, Lau DCW, Vallis M, Sharma AM, Biertho L, Campbell-Scherer D, Adamo K, Alberga A, Bell R, Boul\u00e9 N, Boyling E, Brown J, Calam B, Clarke C, Crowshoe L, Divalentino D, Forhan M, Freedhoff Y, Gagner M, Glazer S, Grand C, Green M, Hahn M, Hawa R, Henderson R, Hong D, Hung P, Janssen I, Jacklin K, Johnson-Stoklossa C, Kemp A, Kirk S, Kuk J, Langlois MF, Lear S, McInnes A, Macklin D, Naji L, Manjoo P, Morin MP, Nerenberg K, Patton I, Pedersen S, Pereira L, Piccinini-Vallis H, Poddar M, Poirier P, Prud\u2019homme D, Salas XR, Rueda-Clausen C, Russell-Mayhew S, Shiau J, Sherifali D, Sievenpiper J, Sockalingam S, Taylor V, Toth E, Twells L, Tytus R, Walji S, Walker L, Wicklum S (2020) Obesity in adults: a clinical practice guideline. CMAJ 192:E875\u2013E891. https:\/\/doi.org\/10.1503\/cmaj.191707","journal-title":"CMAJ"},{"key":"1402_CR20","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-19-0893","volume":"182","author":"R Pasquali","year":"2020","unstructured":"Pasquali R, Casanueva F, Haluzik M, van Hulsteijn L, Ledoux S, Monteiro MP, Salvador J, Santini F, Toplak H, Dekkers OM (2020) European Society of Endocrinology Clinical Practice Guideline: endocrine work-up in obesity. Eur J Endocrinol 182:G1\u2013G32. https:\/\/doi.org\/10.1530\/EJE-19-0893","journal-title":"Eur J Endocrinol"},{"key":"1402_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/ijo.2009.2","volume":"33","author":"AM Sharma","year":"2009","unstructured":"Sharma AM, Kushner RF (2009) A proposed clinical staging system for obesity. Int J Obes 33:289\u2013295. https:\/\/doi.org\/10.1038\/ijo.2009.2","journal-title":"Int J Obes"},{"key":"1402_CR22","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1038\/s41366-021-00856-9","volume":"45","author":"S Bettini","year":"2021","unstructured":"Bettini S, Quinto G, Neunhaeuserer D, Battista F, Belligoli A, Milan G, Gasperetti A, Vettor R, Ermolao A, Busetto L (2021) Edmonton obesity staging system: an improvement by cardiopulmonary exercise testing. Int J Obes 45:1949\u20131957. https:\/\/doi.org\/10.1038\/s41366-021-00856-9","journal-title":"Int J Obes"},{"issue":"Suppl 1","key":"1402_CR23","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","volume":"43","author":"American Diabetes Association","year":"2020","unstructured":"American Diabetes Association (2020) Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care 43(Suppl 1):S14\u2013S31. https:\/\/doi.org\/10.2337\/dc20-S002","journal-title":"Diabetes Care"},{"key":"1402_CR24","unstructured":"Associazione Medici Diabetologi (AMD)-Societ\u00e0 Italiana di Diabetologia (SID) (2018) Standard italiani per la cura del Diabete Mellito 2018. https:\/\/aemmedi.it\/wp-content\/uploads\/2009\/06\/AMD-Standard-unico1.pdf"},{"key":"1402_CR25","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/S0140-6736(17)30069-7","volume":"389","author":"CW le Roux","year":"2017","unstructured":"le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DCW, Van Gaal L, Ortiz RV, Wilding JPH, Skj\u00f8th TV, Manning LS, Pi-Sunyer X, SCALE Obesity Prediabetes NN8022-1839 Study Group (2017) 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet 389:1399\u20131409. https:\/\/doi.org\/10.1016\/S0140-6736(17)30069-7","journal-title":"Lancet"},{"key":"1402_CR26","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1001\/jama.2018.7777","volume":"320","author":"EL LeBlanc","year":"2018","unstructured":"LeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O\u2019Connor EA (2018) Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: an updated systematic review for the U.S. Preventive Services Task Force. JAMA 320:1172\u20131191. https:\/\/doi.org\/10.1001\/jama.2018.7777","journal-title":"JAMA"},{"key":"1402_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/joim.12012","volume":"273","author":"L Sj\u00f6str\u00f6m","year":"2013","unstructured":"Sj\u00f6str\u00f6m L (2013) Review of the key results from the Swedish Obese Subjects (SOS) trial\u2014a prospective controlled intervention study of bariatric surgery. J Intern Med 273:219\u2013234. https:\/\/doi.org\/10.1111\/joim.12012","journal-title":"J Intern Med"},{"key":"1402_CR28","unstructured":"Societ\u00e0 Italiana di Chirurgia dell\u2019Obesit\u00e0 e delle malattie metaboliche. Linee Guida di Chirurgia dell\u2019Obesit\u00e0. Edizione 2016"},{"key":"1402_CR29","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s11695-016-2271-4","volume":"26","author":"M De Luca","year":"2016","unstructured":"De Luca M, Angrisani L, Himpens J, Busetto L, Scopinaro N, Weiner R, Sartori A, Stier C, Lakdawala M, Bhasker AG, Buchwald H, Dixon J, Chiappetta S, Kolberg HC, Fr\u00fchbeck G, Sarwer DB, Suter M, Soricelli E, Bl\u00fcher M, Vilallonga R, Sharma A, Shikora S (2016) Indications for surgery for obesity and weight-related diseases: position statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg 26:1659\u20131696. https:\/\/doi.org\/10.1007\/s11695-016-2271-4","journal-title":"Obes Surg"},{"key":"1402_CR30","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1177\/0956797615601103","volume":"26","author":"AR Sutin","year":"2015","unstructured":"Sutin AR, Stephan Y, Terracciano A (2015) Weight discrimination and risk of mortality. Psychol Sci 26:1803\u20131811. https:\/\/doi.org\/10.1177\/0956797615601103","journal-title":"Psychol Sci"},{"key":"1402_CR31","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/ijo.2016.52","volume":"40","author":"A Blackman","year":"2016","unstructured":"Blackman A, Foster GD, Zammit G, Rosenberg R, Aronne L, Wadden T, Claudius B, Jensen CB, Mignot E (2016) Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. Int J Obes 40:1310\u20131319. https:\/\/doi.org\/10.1038\/ijo.2016.52","journal-title":"Int J Obes"},{"key":"1402_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3945\/ajcn.111.024927","volume":"95","author":"WT Garvey","year":"2012","unstructured":"Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA, Schwiers M, Day WW, Bowden CH (2012) Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-con-trolled, phase 3 extension study. Am J Clin Nutr 95:297\u2013308. https:\/\/doi.org\/10.3945\/ajcn.111.024927","journal-title":"Am J Clin Nutr"},{"key":"1402_CR33","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.joca.2016.01.984","volume":"24","author":"AS Gersing","year":"2016","unstructured":"Gersing AS, Solka M, Joseph GB, Schwaiger BJ, Heilmeier U, Feuerriegel G, Nevitt MC, McCulloch CE, Link TM (2016) Progression of cartilage degeneration and clinical symptoms in obese and overweight individuals is dependent on the amount of weight loss: 48-month data from the Osteoarthritis Initiative. Osteoarthritis Cartilage 24:1126\u20131134. https:\/\/doi.org\/10.1016\/j.joca.2016.01.984","journal-title":"Osteoarthritis Cartilage"},{"key":"1402_CR34","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","volume":"374","author":"Diabetes Prevention Program Research Group","year":"2009","unstructured":"Diabetes Prevention Program Research Group (2009) 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374:1677\u20131686. https:\/\/doi.org\/10.1016\/S0140-6736(09)61457-4","journal-title":"Lancet"},{"key":"1402_CR35","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S2213-8587(16)30162-0","volume":"4","author":"Look AHEAD Research Group","year":"2016","unstructured":"Look AHEAD Research Group (2016) Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol 4:913\u2013921. https:\/\/doi.org\/10.1016\/S2213-8587(16)30162-0","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1402_CR36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jama.2011.1914","volume":"307","author":"L Sjostrom","year":"2012","unstructured":"Sjostrom L, Peltonen M, Jacobson P, Sj\u00f6str\u00f6m CD, Karason K, Wedel H, Ahlin S, Anveden \u00c5, Bengtsson C, Bergmark G, Bouchard C, Carlsson B, Dahlgren S, Karlsson J, Lindroos AK, L\u00f6nroth H, Narbro K, N\u00e4slund I, Olbers T, Svensson PA, Carlsson LM (2012) Bariatric surgery and long-term cardiovascular events. JAMA 307:56\u201365. https:\/\/doi.org\/10.1001\/jama.2011.1914","journal-title":"JAMA"},{"key":"1402_CR37","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1056\/NEJMoa1112082","volume":"367","author":"LM Carlsson","year":"2012","unstructured":"Carlsson LM, Peltonen M, Ahlin S, Anveden \u00c5, Bouchard C, Carlsson B, Jacobson P, L\u00f6nroth H, Maglio C, N\u00e4slund I, Pirazzi C, Romeo S, Sj\u00f6holm K, Sj\u00f6str\u00f6m E, Wedel H, Svensson PA, Sj\u00f6str\u00f6m L (2012) Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 367:695\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa1112082","journal-title":"N Engl J Med"},{"key":"1402_CR38","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/s41366-021-00788-4","volume":"45","author":"CL Haase","year":"2021","unstructured":"Haase CL, Lopes S, Olsen AH, Satylganova A, Schnecke V, McEwan P (2021) Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database. Int J Obes 45:1249\u20131258. https:\/\/doi.org\/10.1038\/s41366-021-00788-4","journal-title":"Int J Obes"},{"key":"1402_CR39","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40519-016-0279-3","volume":"21","author":"F Santini","year":"2016","unstructured":"Santini F, Busetto L, Cresci B, Sbraccia P (2016) SIO management algorithm for patients with overweight or obesity: consensus statement of the Italian Society for Obesity (SIO). Eat Weight Disord 21:305\u2013307. https:\/\/doi.org\/10.1007\/s40519-016-0279-3","journal-title":"Eat Weight Disord"},{"key":"1402_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s40519-021-01217-1","author":"L Busetto","year":"2021","unstructured":"Busetto L, Sbraccia P, Vettor R (2021) Obesity management: at the forefront against disease stigma and therapeutic inertia. Eat Weight Disord. https:\/\/doi.org\/10.1007\/s40519-021-01217-1","journal-title":"Eat Weight Disord"},{"key":"1402_CR41","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.jada.2007.07.017","volume":"107","author":"MJ Franz","year":"2007","unstructured":"Franz MJ, VanWormer JJ, Crain AL, Boucher JL, Histon T, Caplan W, Bowman JD, Pronk NP (2007) Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 107:1755\u20131767. https:\/\/doi.org\/10.1016\/j.jada.2007.07.017","journal-title":"J Am Diet Assoc"},{"key":"1402_CR42","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1056\/NEJMoa1109220","volume":"365","author":"TA Wadden","year":"2011","unstructured":"Wadden TA, Volger S, Sarwer DB, Vetter ML, Tsai AG, Berkowitz RI, Kumanyika S, Schmitz KH, Diewald LK, Barg R, Chittams J, Moore RH (2011) A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med 365:1969\u20131979. https:\/\/doi.org\/10.1056\/NEJMoa1109220","journal-title":"N Engl J Med"},{"key":"1402_CR43","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1467-789X.2009.00689.x","volume":"11","author":"AM Sharma","year":"2010","unstructured":"Sharma AM, Padwal R (2010) Obesity is a sign\u2014over-eating is a symptom: an aetiological framework for the assessment and management of obesity. Obes Rev 11:362\u2013370. https:\/\/doi.org\/10.1111\/j.1467-789X.2009.00689.x","journal-title":"Obes Rev"},{"key":"1402_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2021.01.002","volume":"93","author":"L Busetto","year":"2021","unstructured":"Busetto L, Bettini S, Makaronidis J, Roberts CA, Halford JCG, Batterham RL (2021) Mechanisms of weight regain. Eur J Intern Med 93:3\u20137. https:\/\/doi.org\/10.1016\/j.ejim.2021.01.002","journal-title":"Eur J Intern Med"}],"container-title":["Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40519-022-01402-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40519-022-01402-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40519-022-01402-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T16:11:27Z","timestamp":1665591087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40519-022-01402-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,17]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["1402"],"URL":"https:\/\/doi.org\/10.1007\/s40519-022-01402-w","relation":{},"ISSN":["1590-1262"],"issn-type":[{"value":"1590-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,17]]},"assertion":[{"value":"28 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LB reports Advisory Boards: Novo Nordisk. Speaker: Bruno Farmaceutici and Therasience; FG reports Advisory Boards: AstraZeneca; Eli Lilly; Novo Nordisk; Roche Diabetes Care, Sanofi. Consultant: Boehringer Ingelheim; Lifescan; Merck Sharp & Dohme; Sanofi, AstraZeneca, Medimmune, Roche Diabetes Care, Sanofi, Medtronic. Research support: Eli Lilly, Roche Diabetes Care; FS has worked as a consultant, participated in studies, and\/or received travel funds from the following companies, which are involved with obesity and related diseases: AstraZeneca, Aegerion Pharmaceuticals, Fujirebio, Pfizer, Amryt, BioItalia, Bruno farmaceutici, Damor pharmaceuticals and Novo Nordisk, GM reports Roche Diagnostici. The remaining authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}